Prospective Clinical Trial on dosage Optimizing of Tranexamic Acid in Non-Emergency Cardiac Surgery Procedures
After withdrawal of aprotinin in 2008 only tranexamic acid (TxA, Cyclocapron, Pfitzer, Germany) remains available as antihyperfibrinolytic agent in Europe.